The following article is sponsored by Lantern Pharma. The information contained in this article in no way represents investment advice or opinion on the ...
Seagen Inc. (SGEN) and Astellas Pharma (ALPMF)announced the interimresults from thephase 3 EV-301 trialcomparing PADCEV (enfortumab vedotin-ejfv) to chemotherapy in adult patients...
Seagen Inc. (NASDAQ:SGEN) Q4 2020 Earnings Conference Call February 11, 2021 4:30 PM ET Company Participants Peggy Pinkston – Vice President of Investor Relations Clay Siegall – President...
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Feb. 11) 10X ...
Seagen Inc. shares are up 15.8% to $191.48 in late afternoon trading. One Twitter user mentioned that the sudden rise may be due to potential inclusion in the S&P 500.